Checked.be
Active
BE 0799.278.713Private limited company
VETAPHARMA BELGIUM
Rue Pont-à-Migneloux 39 ·6041 Charleroi, Belgium· 3 yrs active
Sector: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
(70200)
Conclusion
The computed 12-month bankruptcy probability of VETAPHARMA BELGIUM is 0.7% (low). The 2024 annual accounts show negative equity (€-5k) and a net result of €-15k. Its solvency ranks better than 10% of 973 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 1 annual account.
Key figures
| Equity | €-5k |
| Net result | €-15k |
| Better than sector | 10% |
| Active | 3 yrs |
Snowflake analysis
58
/ 100
Mixed profile: strong on profitability, weaker on health.
Computed on 4 of 5 axes. Not measured: growth. An unmeasured axis is not a zero: no data was read for it.
Health
20
Profitability
100
Solvency
33
Growth
-
Stability
79
Bankruptcy probability (12 mo)
0.7%
Low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector
−Young company
+Annual accounts: weaker financial profile
+
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Risk Assessment
0 / 100
Low riskTrust signals
More than 3 years active
Founded in 2023, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Health barometer
20
/ 100
Critical
Computed from 3 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.
Financial overview
Annual accounts filed on 28-08-2025 with the NBB · fiscal year 2024 · volledig
Sector comparison
Fiscal year 2024 · NACE 70, Head offices & management consulting · compared within the same schema type (full schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -0.2% | 39.6% | |
| Net result | €-15k | €32k | |
| Equity | €-5k | €152k | |
| Gross operating margin | €-14k | €58k | |
| Total assets | €2.18M | €749k |
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
| Fiscal year | 2024 |
|---|---|
| Deposit | volledig |
| Revenue | - |
| EBITDA | - |
| Net profit | €-15k |
| Cash flow | - |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €2.18M |
| Equity | €-5k |
| Debt | €2.19M |
| of which ≤ 1y | €2.09M |
| of which > 1y | €100k |
| Working capital | €-2.08M |
| Employees (FTE) | - |
Ratios (computed)
| 2024 | |
|---|---|
| Current ratio | 0.01 |
| Quick ratio | 0.01 |
| Working capital ratio | -95.1% |
| Solvency | -0.2% |
| Debt / equity | -473.40 |
| Long-term debt ratio | -21.62 |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | -0.7% |
| ROE | 316.2% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €2.18M |
| Fixed assets | 21/28 | €2.17M |
| Financial fixed assets | 28 | €2.17M |
| Current assets | 29/58 | €13k |
| Amounts receivable within one year | 40/41 | €3k |
| Cash & bank | 54/58 | €10k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €2.18M |
| Equity | 10/15 | €-5k |
| Contributions / capital | 10/11 | €10k |
| Accumulated profits (losses) | 14 | €-15k |
| Amounts payable | 17/49 | €2.19M |
| Amounts payable after one year | 17 | €100k |
| Amounts payable within one year | 42/48 | €2.09M |
| Trade debts payable within one year | 44 | €5k |
| Income statement | ||
| Gross operating margin | 9900 | €-14k |
| Operating result | 9901 | €-14k |
| Financial charges | 65 | €358 |
| Result before taxes | 9903 | €-15k |
| Net result for the period | 9904 | €-15k |
| Result to be appropriated | 9905 | €-15k |
Ratios computed by Checked.
Legal Structure
| NACE primary | Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies(70200) |
| Legal form | Private limited company(610) |
| Incorporation | 08-03-2023 |
| Status | Active |
| Postal code | 6041 |
Establishment units
VETAPHARMA BELGIUM
since 20232.342.631.855
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52028B0175/00S000 | Wallonia | 2,223 m² | 1 · 283 m² | 6.2 m · 1 fl. |
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
2025
28-08-2025
NBB filing
Annual accounts filed
Credit advice
AI due-diligence brief
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works
Company registry (CBE)
Activities
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies70200Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering70220Speur- en ontwikkelingswerk op biotechnologisch gebied72101Speur- en ontwikkelingswerk op biotechnologisch gebied72110
Primary activity highlighted.
Names & trade names
| Legal nameFR | VETAPHARMA BELGIUM |
Registered office
Rue Pont-à-Migneloux 39
6041 Charleroi, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies
ADG CONSEILS
BE 0721.996.734 · Charleroi
AEDAS
BE 0477.140.327 · Charleroi
AFOREST BELGIUM
BE 0441.533.607 · Charleroi
ARTIS VISIONARIA
BE 0765.808.862 · Charleroi
ASSETCO
BE 0713.470.830 · Charleroi